ALTOMONTE, MARESA
 Distribuzione geografica
Continente #
NA - Nord America 1.443
EU - Europa 1.361
AS - Asia 780
SA - Sud America 134
AF - Africa 36
OC - Oceania 2
Totale 3.756
Nazione #
US - Stati Uniti d'America 1.427
RU - Federazione Russa 397
SG - Singapore 312
IE - Irlanda 216
GB - Regno Unito 214
CN - Cina 194
DE - Germania 160
VN - Vietnam 135
IT - Italia 118
BR - Brasile 114
SE - Svezia 75
FR - Francia 70
UA - Ucraina 48
HK - Hong Kong 45
ZA - Sudafrica 25
FI - Finlandia 20
ES - Italia 19
IN - India 15
KR - Corea 12
BD - Bangladesh 10
AZ - Azerbaigian 7
MX - Messico 7
AR - Argentina 6
JP - Giappone 6
TR - Turchia 6
CA - Canada 5
IQ - Iraq 5
CO - Colombia 4
EC - Ecuador 4
KG - Kirghizistan 4
NL - Olanda 4
PK - Pakistan 4
SA - Arabia Saudita 4
CH - Svizzera 3
MY - Malesia 3
PL - Polonia 3
AE - Emirati Arabi Uniti 2
AT - Austria 2
AU - Australia 2
BG - Bulgaria 2
ID - Indonesia 2
IM - Isola di Man 2
KZ - Kazakistan 2
MA - Marocco 2
MU - Mauritius 2
NG - Nigeria 2
TN - Tunisia 2
UZ - Uzbekistan 2
VE - Venezuela 2
AM - Armenia 1
BH - Bahrain 1
BO - Bolivia 1
CI - Costa d'Avorio 1
CL - Cile 1
CR - Costa Rica 1
CY - Cipro 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
EE - Estonia 1
EG - Egitto 1
GE - Georgia 1
GT - Guatemala 1
HR - Croazia 1
IL - Israele 1
KH - Cambogia 1
LB - Libano 1
LK - Sri Lanka 1
LT - Lituania 1
LV - Lettonia 1
MK - Macedonia 1
NO - Norvegia 1
NP - Nepal 1
PA - Panama 1
PY - Paraguay 1
SN - Senegal 1
SY - Repubblica araba siriana 1
UY - Uruguay 1
Totale 3.756
Città #
Dublin 215
Singapore 183
Fairfield 166
Southend 166
Ashburn 127
Dallas 122
Moscow 106
Houston 80
Santa Clara 78
Woodbridge 78
Beijing 71
Cambridge 69
Wilmington 69
Seattle 57
Siena 47
Chandler 46
Hong Kong 43
Jacksonville 43
Dong Ket 38
Princeton 37
San Jose 34
Ann Arbor 32
Ho Chi Minh City 32
Dearborn 31
New York 26
Lauterbourg 25
Hanoi 24
The Dalles 23
Johannesburg 21
San Mateo 17
Los Angeles 16
Málaga 15
Helsinki 14
Shanghai 14
Düsseldorf 13
Nanjing 11
San Diego 11
Stockholm 11
São Paulo 11
Portsmouth 10
Buffalo 9
Florence 9
London 9
Orem 9
Council Bluffs 8
Frankfurt am Main 8
Milan 8
Munich 8
Baku 7
Nuremberg 7
Hefei 6
Manchester 6
Nanchang 6
Yongsan-gu 6
Boardman 5
San Giovanni Valdarno 5
Venezia 5
Ankara 4
Boston 4
Hải Dương 4
Jinan 4
Ninh Bình 4
Phoenix 4
Redondo Beach 4
Tianjin 4
Tokyo 4
Amsterdam 3
Atlanta 3
Belo Horizonte 3
Bogotá 3
Campinas 3
Can Tho 3
Da Nang 3
Dhaka 3
Empoli 3
Goiânia 3
Guangzhou 3
Haiphong 3
Hangzhou 3
Karlsruhe 3
Kunming 3
Mexico City 3
Newark 3
Palermo 3
Rio de Janeiro 3
Rome 3
San Francisco 3
Schwielowsee 3
Seoul 3
St Petersburg 3
Toronto 3
Warsaw 3
Zurich 3
Abuja 2
Altamura 2
Asciano 2
Barnet 2
Bauru 2
Bishkek 2
Brooklyn 2
Totale 2.484
Nome #
Ipilimumab experience in heavily pretreated patients with melanoma in an expanded access program at the University Hospital of Siena (Italy) 342
Long-term survival and immunological parameters in metastatic melanoma patients who responded to ipilimumab 10 mg/kg within an expanded access programme 327
Long-term follow up of metastatic melanoma patients treated with Thymosin alpha-1: investigating immune checkpoints synergy 252
Fourteenth Meeting of the Network Italiano per la Bioterapia dei Tumori (NIBIT) on Cancer Bio-Immunotherapy, Siena, Italy, October 13–15, 2016 236
Targeting cancer vasculature via endoglin/CD105: a novel antibody-based diagnostic and therapeutic strategy in solid tumours 204
Epigenetically regulated clonal heritability of CTA expression profiles in human melanoma 201
Clinical experience with ipilimumab 10 mg/kg in patients with melanoma treated at Italian centres as part of a European expanded access programme 198
Ipilmumab in the daily practice: feasibility, safety, efficacy and long term follow-up in heavily pretreated metastatic melanoma patients 196
The italian experience on the feasibility and safety of ipilmumab therapy in pretracted metastatic melanoma patients 194
Biology and clinical applications of CD40 in cancer treatment 189
CD40 expression by human melanocytic lesions and melanoma cell lines and direct CD40 targeting with the therapeutic anti-CD40 antibody CP-870,893 184
Ipilimumab in the common daily practice: feasibility, safety, efficacy and long-term follow-up in heavily pretreated metastatic melanoma patients 184
Tremelimumab plus durvalumab retreatment and 4-year outcomes in patients with mesothelioma: a follow-up of the open label, non-randomised, phase 2 NIBIT-MESO-1 study 173
Clinical Efficacy of the Anti-Cytotoxic T Lymphocyte Antigen-4 (CTLA-4) Monoclonal Antibody Ipilimumab in Pretreated Metastatic Uveal Melanoma Patients 166
Ipilimumab in the common daily practice: Feasibility, safety, and efficacy in heavily pretreated metastatic melanoma patients 156
Primary hepatic epithelioid hemangioendothelioma progressively responsive to interferon-alpha: is there room for novel anti-angiogenetic treatments? 152
Immune Checkpoint Inhibitors for Cancer Therapy in the COVID-19 Era 138
Clinical experience with ipilimumab 3 mg/kg: Real-world efficacy and safety data from an expanded access programme cohort 116
Tremelimumab combined with durvalumab in patients with mesothelioma (NIBIT-MESO-1): an open-label, non-randomised, phase 2 study 108
Efficacy and safety of an intensified schedule of tremelimumab for chemotherapy-resistant malignant mesothelioma: An open-label, single-arm, phase 2 study 108
Totale 3.824
Categoria #
all - tutte 11.563
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.563


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021110 0 0 0 0 0 0 0 0 0 35 12 63
2021/2022212 18 21 20 3 4 11 7 11 13 26 25 53
2022/2023293 18 23 53 23 16 54 13 23 26 16 20 8
2023/2024292 15 4 23 11 4 78 113 6 5 1 15 17
2024/2025537 11 23 69 17 73 29 5 30 107 31 57 85
2025/20261.243 89 142 98 215 392 51 123 50 27 56 0 0
Totale 3.824